Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.43B
Enterprise Value4.92B
P/E Ratio-36.96
PEG Ratio0.91
Price/Sales Ratio6.65
Price/Book Ratio2.89
Enterprise/Revenue5.78
Enterprise/EBITDA-46.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.18
Operating Margin-0.21
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.08

Income Statement

Revenue768.97M
Revenue/Share0.72
Gross Profit389.07M
EBITDA-79.06M
Net Income-134.71M
Diluted EPS-0.13

Balance Sheet

Total Cash919.68M
Total Cash/Share0.87
Total Debt262.28M
Total Debt/Equity0.15
Current Ratio2.01
Book Value Per Share1.66

Price History

52-Week Change32.22
52-Week High6.86
52-Week Low3.61
Moving Average 50 Days5.86
Moving Average 200 Days5.18

Statistics

Average Volume48.08M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.06
Last Split Factor18:5
Last Split DateMay 24, 2016
AD